Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

FORM (by GBY) vs ShedRx

By GLP-1 ScorecardUpdated

FORMFactor scores not reassessed.
Site position #399

Lower score

ShedRx
Site position #3

Higher score

Score comparison

ShedRx has the higher recorded score — 87/100 to 58.6/100.

ShedRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Shed combines compounded injections and branded Wegovy/Zepbound options with coaching; compare longer-plan supply, fees and guarantee rules before committing.

Before you choose

Before comparing the headline prices, the FORM (by GBY) review and the ShedRx review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, FORM (by GBY) vs Society of You and FormidableMD vs ShedRx compare each of them with another graded program, and the list of alternatives to FORM (by GBY) ranks the programs closest to FORM (by GBY) on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueShedRx +49
35
84
Dose & formulationShedRx +8
88
96
Clinical oversightShedRx +29
55
84
Labs & monitoringShedRx +29
55
84
FulfillmentShedRx +13
75
88
Contract termsShedRx +35
50
85
FORM (by GBY) · top barShedRx · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricFORM (by GBY)ShedRx
WeighScore58.6/10087/100
GradeCB+
Site position#399#3
SemaglutideStand-alone offer $99 first month, then $159; confirm selected quote$199/mo
TirzepatideStand-alone offer $169 first month, then $219; confirm selected quote$299/mo
CoverageConfirm availability for your state and selected treatmentAll 50 states
Brand-name accessYesYes
Oral / sublingualYesYes
FORM (by GBY)

Site position #399 · C

Factor scores not reassessed.

Strengths

  • Publishes distinct first-month and continuing stand-alone prices
  • Lists oral options and separate branded membership pathways

What to consider

  • Confirm the selected formulation, supply and debit
  • Unused subscription time is generally not refunded
ShedRx

Site position #3 · B+

Strengths

  • Published injection plans plus other formulation and branded prescribing options
  • One-month injection prices listed at $199 semaglutide / $299 tirzepatide
  • Terms describe monthly coaching and name six possible pharmacy partners

What to consider

  • Six- and twelve-month plans specify 24 and 48 weeks of medication
  • The 120-day promise has first-time-user and participation requirements and does not cancel a longer plan
  • Branded pages display conflicting $99/$125 membership charges, with medication separate
  • Actual clinician/pharmacy assignment and the applicable minimum term need confirmation

Featured provider

ShedRx

ShedRx scores 87/100 (B+). Shed combines compounded injections and branded Wegovy/Zepbound options with coaching; compare longer-plan supply, fees and guarantee rules before committing.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard